Dignitana AB Publishes Q3 2019 Interim Report
Global expansion is underway - Third quarter marks a major turning pointin the Company's transitionFinancial highlights · Group revenue amounted to 10,374 TSEK, 1,068 KUSD, an increase of 1 percent over the same period 2018. · Year to date Group revenue was 32,484 TSEK, 3,446 KUSD, an increase of 28 percent over the same period 2018. Business highlights · Following FDA clearance, the first DigniCap Delta contract in the U.S. was signed with large healthcare provider Atrium Health. · University of California, San Francisco (UCSF) received the first U.S. installation of